Login / Signup

Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.

Veronique BajzikHannah A DeBergNahir GarabatosBlake J RustKimberly K ObrienQuynh-Anh NguyenColin O'RourkeAlex SmithAlex H WalkerCharlie QuinnVivian H GersukMary FarringtonDavid JeongBrian P VickeryDaniel C AdelmanErik R Wambre
Published in: Allergy (2022)
Oral desensitization therapy with AR101 leads to decreased basophil sensitivity to peanut and reshapes peanut-reactive T effector cell responses supporting its potential as an immunomodulatory therapy.
Keyphrases
  • immune response
  • cell therapy
  • dendritic cells
  • toll like receptor
  • stem cells
  • mesenchymal stem cells
  • bone marrow
  • atopic dermatitis